SAVELLA (Milnacipran)

SAVELLA (Milnacipran) is a prescription medication primarily used for the management of fibromyalgia, a chronic condition characterized by widespread pain, fatigue, and tenderness in the muscles, ligaments, and tendons. This medication belongs to a class of drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs), which work by balancing certain neurotransmitters in the brain to help improve mood and alleviate pain.

Key highlights of SAVELLA include:

• FDA Approved: SAVELLA is specifically approved by the FDA for the treatment of fibromyalgia in adults.


• Mechanism of Action: It increases the levels of serotonin and norepinephrine, neurotransmitters that play a crucial role in regulating mood and pain perception.


• Dosage: The typical dosing regimen starts at a lower dose and may be gradually increased based on patient response and tolerance, ensuring safety and efficacy.


• Side Effects: Common side effects may include nausea, constipation, headache, and increased sweating. It's important for patients to discuss potential side effects with their healthcare provider.


• Contraindications: SAVELLA should not be used in combination with monoamine oxidase inhibitors (MAOIs) or in individuals with uncontrolled hypertension.


• Monitoring: Regular monitoring by healthcare professionals is recommended to assess the effectiveness of the treatment and make any necessary adjustments.


• Patient Education: Patients should be educated about the potential risks and benefits of the medication, along with lifestyle modifications that may enhance treatment outcomes.

Overall, SAVELLA offers a viable option for individuals suffering from fibromyalgia, helping to improve their quality of life by managing symptoms effectively. Always consult a healthcare professional before starting any new medication.

• Milnacipran


• Inactive ingredients


• Microcrystalline cellulose


• Hydroxypropyl cellulose


• Magnesium stearate


• Silicon dioxide


• Coloring agents

Savella, which contains the active ingredient Milnacipran, is a medication primarily used to treat fibromyalgia. It is important to follow your healthcare provider's instructions when using this medication to ensure safety and effectiveness.

Before starting Savella, inform your doctor about any existing medical conditions, especially if you have a history of heart problems, high blood pressure, or liver issues. Disclose all medications you are currently taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.

When using Savella, adhere to the following instructions:

1. Dosage: Take Savella exactly as prescribed by your healthcare provider. Typically, treatment begins with a low dose, which may be gradually increased based on your response and tolerance.


2. Administration: Savella is usually taken orally, with or without food. Swallow the capsule whole with a glass of water. Do not crush or chew the capsules, as this may affect the medication's efficacy.


3. Timing: Take Savella at the same time each day to maintain a consistent level of the medication in your system. Setting a daily reminder can help you stay on track.


4. Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.


5. Discontinuation: Do not stop taking Savella abruptly without consulting your healthcare provider, as this may lead to withdrawal symptoms. Your doctor will guide you on how to taper off the medication safely if necessary.

While taking Savella, monitor for side effects, such as nausea, headache, or increased heart rate. Report any severe side effects or signs of an allergic reaction to your doctor immediately. Regular follow-up appointments are essential to assess your progress and make any necessary adjustments to your treatment plan.

Always store Savella in a cool, dry place away from direct sunlight and out of reach of children. Dispose of any unused medication according to local regulations to prevent accidental ingestion.